title: Role of tetrahydrobiopterin (BH4) in hyperhomocysteinemia-induced endothelial dysfuction: new indication for this orphan-drug?
authors.forename: Rinrada
authors.initials: R
authors.lastname: Kietadisorn
authors.forename: Bas L
authors.initials: BL
authors.lastname: Kietselaer
authors.forename: Harald H H W
authors.initials: HH
authors.lastname: Schmidt
authors.forename: An L
authors.initials: AL
authors.lastname: Moens
mesh_terms: D001708:Biopterins / Q000031:analogs & derivatives* / Q000032:analysis / Q000378:metabolism / Q000502:physiology; D003326:Coronary Circulation / Q000502:physiology; D003327:Coronary Disease / Q000209:etiology / Q000473:pathology; D003331:Coronary Vessels / Q000000981:diagnostic imaging; D004730:Endothelium, Vascular / Q000473:pathology*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000000981:diagnostic imaging / Q000378:metabolism*; D009569:Nitric Oxide / Q000097:blood; D009965:Orphan Drug Production; D010084:Oxidation-Reduction; D014463:Ultrasonography; D014652:Vascular Diseases / Q000473:pathology*
chemical_list: D001708:Biopterins; D009569:Nitric Oxide; C003402:sapropterin